128 related articles for article (PubMed ID: 37868945)
1. Out-of-Field Dose Measurement by TLD Dosimetry and Estimation of Radiation-Induced Secondary Cancer Risk of Thyroid and Breast from Head Radiotherapy.
Rahbar Yazdi S; Zare MH; Broomand MA
J Biomed Phys Eng; 2023 Oct; 13(5):403-410. PubMed ID: 37868945
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the Thyroid Secondary Cancer Risk on the Patient of Standard Breast External Beam Radiotherapy.
Momeni Z; Tavakoli MB; Atarod M
J Med Signals Sens; 2018; 8(4):238-243. PubMed ID: 30603616
[TBL] [Abstract][Full Text] [Related]
3. Secondary cancer risk after whole-breast radiation therapy: field-in-field versus intensity modulated radiation therapy versus volumetric modulated arc therapy.
Haciislamoglu E; Cinar Y; Gurcan F; Canyilmaz E; Gungor G; Yoney A
Br J Radiol; 2019 Oct; 92(1102):20190317. PubMed ID: 31295011
[TBL] [Abstract][Full Text] [Related]
4. Whole-body dose and energy measurements in radiotherapy by a combination of LiF:Mg,Cu,P and LiF:Mg,Ti.
Hauri P; Schneider U
Z Med Phys; 2018 Apr; 28(2):96-109. PubMed ID: 28807441
[TBL] [Abstract][Full Text] [Related]
5. Measurement of Thyroid Dose by TLD arising from Radiotherapy of Breast Cancer Patients from Supraclavicular Field.
Farhood B; Bahreyni Toossi MT; Vosoughi H; Khademi S; Knaup C
J Biomed Phys Eng; 2016 Sep; 6(3):147-156. PubMed ID: 27853722
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Thyroid Lobe Dose in Breast Cancer Intraoperative Radiotherapy.
Ramezani Farkhani R; Gholamhosseinian H; Anvari K; Forghani MN
J Biomed Phys Eng; 2021 Feb; 11(1):55-60. PubMed ID: 33564640
[TBL] [Abstract][Full Text] [Related]
7. Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects.
Inskip PD; Sigurdson AJ; Veiga L; Bhatti P; Ronckers C; Rajaraman P; Boukheris H; Stovall M; Smith S; Hammond S; Henderson TO; Watt TC; Mertens AC; Leisenring W; Stratton K; Whitton J; Donaldson SS; Armstrong GT; Robison LL; Neglia JP
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):800-7. PubMed ID: 26972653
[TBL] [Abstract][Full Text] [Related]
8. Estimation of Absorbed Dose of the Thyroid Gland in Patients Undergoing 64-Slice Head Computed Tomography and Comparison the Results with ImPACT Software and Computed Tomography Scan Dose Index.
Maziar A; Paydar R; Azadbakht G; Shahbazi-Gahrouei D
J Med Signals Sens; 2019; 9(3):190-195. PubMed ID: 31544059
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the consistency of location of the most severe acute skin reaction and highest skin dose measured by thermoluminescent dosimeter during radiotherapy for breast cancer.
Sun LM; Huang CJ; Chen HY; Chang GH; Tsao MJ
Med Dosim; 2016; 41(3):216-20. PubMed ID: 27158022
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional conformal radiotherapy (3D-CRT) vs. volumetric modulated arc therapy (VMAT) in deep inspiration breath-hold (DIBH) technique in left-sided breast cancer patients-comparative analysis of dose distribution and estimation of projected secondary cancer risk.
Racka I; Majewska K; Winiecki J
Strahlenther Onkol; 2023 Jan; 199(1):90-101. PubMed ID: 35943553
[TBL] [Abstract][Full Text] [Related]
11. Assessment of leakage dose
Lonski P; Kron T; Taylor M; Phipps A; Franich R; Chua B
Phys Imaging Radiat Oncol; 2018 Jan; 5():97-101. PubMed ID: 33458377
[TBL] [Abstract][Full Text] [Related]
12. Special radiobiological features of second cancer risk after particle radiotherapy.
Trott KR
Phys Med; 2017 Oct; 42():221-227. PubMed ID: 29103987
[TBL] [Abstract][Full Text] [Related]
13. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients.
Weber DC; Johanson S; Peguret N; Cozzi L; Olsen DR
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):490-7. PubMed ID: 20800383
[TBL] [Abstract][Full Text] [Related]
14. Radiation-induced hypothyroidism after treatment of head and neck cancer.
Feen Rønjom M
Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931197
[TBL] [Abstract][Full Text] [Related]
15. Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks.
Murray L; Sethugavalar B; Robertshaw H; Bayman E; Thomas E; Gilson D; Prestwich RJ
Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):401-10. PubMed ID: 25840609
[TBL] [Abstract][Full Text] [Related]
16. Thyroid dose from common head and neck CT examinations in children: is there an excess risk for thyroid cancer induction?
Mazonakis M; Tzedakis A; Damilakis J; Gourtsoyiannis N
Eur Radiol; 2007 May; 17(5):1352-7. PubMed ID: 17021703
[TBL] [Abstract][Full Text] [Related]
17. Secondary cancer risk after radiation therapy for breast cancer with different radiotherapy techniques.
Zhang Q; Liu J; Ao N; Yu H; Peng Y; Ou L; Zhang S
Sci Rep; 2020 Jan; 10(1):1220. PubMed ID: 31988348
[TBL] [Abstract][Full Text] [Related]
18. Mammary Chain Irradiation in Left-Sided Breast Cancer: Can We Reduce the Risk of Secondary Cancer and Ischaemic Heart Disease with Modern Intensity-Modulated Radiotherapy Techniques?
Figlia V; Simonetto C; Eidemüller M; Naccarato S; Sicignano G; De Simone A; Ruggieri R; Mazzola R; Matuschek C; Bölke E; Pazos M; Niyazi M; Belka C; Alongi F; Corradini S
Breast Care (Basel); 2021 Aug; 16(4):358-367. PubMed ID: 34602941
[TBL] [Abstract][Full Text] [Related]
19. Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease : Effects of modern radiotherapy techniques.
Corradini S; Ballhausen H; Weingandt H; Freislederer P; Schönecker S; Niyazi M; Simonetto C; Eidemüller M; Ganswindt U; Belka C
Strahlenther Onkol; 2018 Mar; 194(3):196-205. PubMed ID: 28916844
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
